Smart Money Alert

Sai Life Sciences Limited

DecreasedQuarterly

SAILIFEPharmaceuticalsMarket Cap₹32K Cr

Stake

7.44% → 7.43%

Holding

1.58 Cr shares

Change

−15,781 shares

As of

Sept 2026

Since alert−1.2%₹1,505.60 → ₹1,487.90

Nifty 50+1.3%

Invesco Mutual Fund

Mutual Fund

The move

Invesco Mutual Fund trimmed its stake in Sai Life Sciences Limited from 7.44% to 7.43%, selling 15,781 shares.

About Sai Life Sciences Limited

Visit stock

A contract research and manufacturing organization serving the pharmaceutical and biotechnology industries, Sai Life Sciences conducts research activities and produces customized solutions for clients globally. Incorporated in 1999, the company operates as a specialized service provider, offering integrated capabilities across drug development, formulation, and manufacturing to support its customers' product pipelines and commercial operations in India and international markets.

About Invesco Mutual Fund

Visit investor

Indian subsidiary of Invesco Ltd, a US-listed global investment manager with over USD 1.8 trillion in AUM worldwide. Manages over Rs 1.2 lakh crore in India. Known for its Invesco India Contra Fund, which runs a contrarian, undervalued stock strategy against consensus market positioning. One of the few global AMC franchises maintaining a strong active equity presence in India.

Get the next move the moment it happens.

Follow Invesco Mutual Fund and Sai Life Sciences Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Sai Life Sciences Limited shareholders Invesco Mutual Fund's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Sai Life Sciences Limited

Max Life InsuranceDecreased

Max Life Insurance reduced its stake in Sai Life Sciences from 1.54% to 1.52%, selling 49,895 shares.

7 Oct 2026

BlackRock

Direction, size, price and stake change for this move, with what it means for the company.